aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
EchoNous, founded with the mission to revolutionize medical imaging through artificial intelligence, focuses on developing advanced ultrasound devices. The company's vision is to enhance point-of-care diagnostics by integrating deep learning algorithms into miniaturized ultrasound technology. EchoNous offers products like Kosmos AI and Kosmos Plus, which provide clinicians with rapid and precise assessments of the heart, lungs, and abdomen. Their market focus is primarily on healthcare providers seeking cost-effective, portable, and high-performance ultrasound solutions.
Notable figures associated with EchoNous include experts in medical devices and AI technology, though specific names are not provided. The company has attracted significant investment from venture capital firms specializing in healthcare innovation. Key achievements include the successful development and deployment of their Kosmos product line, which has been recognized for its advanced imaging capabilities and affordability. EchoNous has made a substantial impact on the medical field by making sophisticated diagnostic tools more accessible and efficient for clinicians worldwide.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private Equity
Main Product(s)
Medical Devices, Ultrasound
Technology
AI, Machine Learning
Tags
Healthtech, AI
Model Types
Hardware, Software
Revenue Type(s)
Transactional, Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was EchoNous founded?
EchoNous was founded in 2016.
Where is EchoNous’s headquarters located?
EchoNous’s headquarters is located in London, GB.
When was EchoNous’s last funding round?
EchoNous’s most recent funding round was for $7M (USD) in July 2023.
How many employees does EchoNous have?
EchoNous has 136 employees as of Feb 5, 2024.
How much has EchoNous raised to-date?
As of July 05, 2023, EchoNous has raised a total of $194M (USD) since Jul 11, 2023.
Add Comparison
Total Raised to Date
$194M
USD
Last Update Jul 11, 2023
Last Deal Details
$7M
USD
Jul 11, 2023
Series Unknown
Total Employees Over Time
136
As of Feb 2024
EchoNous Address
London,
Greater London
WC1N 2EB
United Kingdom
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts